Baseline absolute lymphocyte count, C-reactive protein, and ferritin predict CAR T cell-related toxicities and outcomes in multiple myeloma [0.03%]
基线淋巴细胞计数、C反应蛋白和铁蛋白预测多发性骨髓瘤CAR-T细胞相关毒性及预后
Darren Pan,Tarek H Mouhieddine,Tianxiang Sheng et al.
Darren Pan et al.
Reduced relapse rate and improved GVHD/relapse free survival (GRFS) with pharmacokinetics-guided busulfan conditioning regimen for allogeneic stem cell transplantation in adult patients with myeloid hematologic malignancies [0.03%]
基于药代动力学指导的布舒芬作为预处理方案可降低成人髓系血液系统恶性肿瘤异基因干细胞移植患者复发率并改善移植物抗宿主病/无复发生存期（GRFS）
Jacopo Mariotti,Chiara De Philippis,Simona De Gregori et al.
Jacopo Mariotti et al.
Clinical outcomes of third-line therapy for aGvHD with gastrointestinal involvement after steroids and ruxolitinib failure [0.03%]
类固醇和鲁索利替尼治疗失败后肠道受累三线移植物抗宿主病的临床疗效
Johannes Clausen,José Antonio Pérez Simón,Martin Carré et al.
Johannes Clausen et al.
CHRONOS is a multicenter, retrospective, cohort study involving acute graft-versus-host disease (aGvHD) adult patients with gastrointestinal (GI) symptoms, steroid- and ruxolitinib refractory, who initiated third-line therapy between 30 May...
Risk factors for alloimmune lung syndromes after allogeneic hematopoietic cell transplantation in children [0.03%]
儿童异基因造血细胞移植后肺过敏综合征的危险因素
Linde Dekker,Birgitta A Versluys,Coco C H de Koning et al.
Linde Dekker et al.
The non-infectious pulmonary complications idiopathic pneumonia syndrome (IPS) and bronchiolitis obliterans syndrome (BOS) are important causes of morbidity and mortality after allogeneic hematopoietic cell transplantation (allo-HCT). To id...
Incidence and outcome of hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: a survey of the infectious diseases working party of EBMT [0.03%]
出库移植后出血性膀胱炎的发病率和结局：欧洲血液和骨髓移植感染工作组调查结果
Simone Cesaro,Chiara Garonzi,Gloria Tridello et al.
Simone Cesaro et al.
Bronchiectasis in patients with bronchiolitis obliterans syndrome: toward phenotyping BOS? [0.03%]
支气管闭塞综合征患者的支气管扩张：迈向BOS分型？
Louise Bondeelle,Ingrid Berger,Gabrielle Archer et al.
Louise Bondeelle et al.
Peripheral blood stem cells versus bone marrow graft for non-T-depleted haploidentical transplantation with post-transplant cyclophosphamide in patients with secondary acute myeloid leukemia in first complete remission: A study from the ALWP/EBMT [0.03%]
次级急性髓系白血病第一次完全缓解中同种异体骨髓移植后环磷酰胺外周血干细胞与骨髓移植物的对比：来自ALWP / EBMT的一项研究
Arnon Nagler,Ryszard Swoboda,Allain-Thibeault Ferhat et al.
Arnon Nagler et al.
Haploidentical stem cell transplantation (haplo-HSCT) with post-transplant cyclophosphamide (PTCy) is a therapeutic option for secondary acute myeloid leukemia (sAML). The study aimed to compare peripheral blood stem cells (PBSC) vs. bone m...
The safety and efficacy of belumosudil and ruxolitinib combination in ruxolitinib refractory cGVHD [0.03%]
布洛莫硫酸盐与鲁索利替尼联合治疗对鲁索利替尼耐药的慢性移植物抗宿主病的安全性和有效性研究
Yibo Wu,Lizhen Liu,Yi Chen et al.
Yibo Wu et al.
Allogeneic hematopoietic stem cell transplantation after azacitidine and venetoclax salvage in relapsed/refractory AML: a multicenter real-world study by the French AURAML group [0.03%]
法国AURAML组的一项多中心真实世界研究：复发/难治性急性髓系白血病经阿扎胞苷和维奈克拉挽救治疗后的同种异体造血干细胞移植
Urbain Tauveron-Jalenques,Gaspar Aspas Requena,Zofia Gross et al.
Urbain Tauveron-Jalenques et al.
Fit relapsed/refractory (R/R) acute myeloid leukemia (AML) patients usually undergo intensive chemotherapy (IC)-based salvage to bridge them to allogeneic hematopoietic stem cell transplantation (HSCT), but their prognosis remains poor. Aza...
Real-world evaluation of belumosudil for chronic ocular graft-versus-host-disease: Efficacy and outcomes [0.03%]
Belumosudil治疗慢性眼睑移植物抗宿主病的真实世界疗效及结局
Leonie Menghesha,Tim Richardson,Jana Knuever et al.
Leonie Menghesha et al.